<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 20:14:09 -0700</creation_date>
  <update_date>2013-05-27 10:59:11 -0600</update_date>
  <accession>HMDBP08701</accession>
  <secondary_accessions>
    <accession>14422</accession>
  </secondary_accessions>
  <protein_type>Unknown</protein_type>
  <synonyms>
    <synonym>Acyl-CoA synthetase medium-chain family member 3</synonym>
    <synonym>Butyrate--CoA ligase 3</synonym>
    <synonym>Butyryl-coenzyme A synthetase 3</synonym>
    <synonym>Middle-chain acyl-CoA synthetase 3</synonym>
    <synonym>Protein SA homolog</synonym>
  </synonyms>
  <gene_name>ACSM3</gene_name>
  <general_function>Involved in catalytic activity</general_function>
  <specific_function>Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4-unsaturated acids (in vitro) (By similarity).
</specific_function>
  <pathways>
    <pathway>
      <name>Butanoate metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00650</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00547</accession>
      <name>Magnesium</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01338</accession>
      <name>Palmityl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06497</accession>
      <name>Heptadecanoyl CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01114</accession>
      <name>Stearoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04258</accession>
      <name>Eicosanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01206</accession>
      <name>Acetyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01275</accession>
      <name>Propionyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01088</accession>
      <name>Butyryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13037</accession>
      <name>Pentanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB12969</accession>
      <name>Heptanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01070</accession>
      <name>Octanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13028</accession>
      <name>Nonanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06404</accession>
      <name>Decanoyl-CoA (n-C10:0CoA)</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13114</accession>
      <name>Undecanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03571</accession>
      <name>Lauroyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06526</accession>
      <name>Tetracosanoyl-CoA  </name>
    </metabolite>
    <metabolite>
      <accession>HMDB02009</accession>
      <name>Crotonoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01290</accession>
      <name>Glutaconyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03944</accession>
      <name>trans-2-Hexenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03949</accession>
      <name>(2E)-Octenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03948</accession>
      <name>(2E)-Decenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03946</accession>
      <name>(2E)-Tetradecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB04257</accession>
      <name>3Z-dodecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03712</accession>
      <name>(2E)-Dodecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01243</accession>
      <name>Isobutyryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB11660</accession>
      <name>2-Methylhexanoyl-CoA </name>
    </metabolite>
    <metabolite>
      <accession>HMDB01113</accession>
      <name>Isovaleryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02057</accession>
      <name>Pristanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00039</accession>
      <name>Butyric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00892</accession>
      <name>Valeric acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00535</accession>
      <name>Caproic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00666</accession>
      <name>Heptanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00847</accession>
      <name>Pelargonic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00947</accession>
      <name>Undecanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01041</accession>
      <name>2-Methylbutyryl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02307</accession>
      <name>Acrylyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03945</accession>
      <name>(2E)-Hexadecenoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06529</accession>
      <name>trans-Octadec-2-enoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02845</accession>
      <name>Hexanoyl-CoA</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00538</accession>
      <name>Adenosine triphosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01423</accession>
      <name>Coenzyme A</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00045</accession>
      <name>Adenosine monophosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00250</accession>
      <name>Pyrophosphate</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>mitochondrial matrix</description>
      <go_id>GO:0005759</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>ATP binding</description>
      <go_id>GO:0005524</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>butyrate-CoA ligase activity</description>
      <go_id>GO:0047760</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>fatty acid ligase activity</description>
      <go_id>GO:0015645</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>metal ion binding</description>
      <go_id>GO:0046872</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>cholesterol homeostasis</description>
      <go_id>GO:0042632</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>fatty acid biosynthetic process</description>
      <go_id>GO:0006633</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of blood pressure</description>
      <go_id>GO:0008217</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Mitochondrion matrix</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>16</chromosome_location>
    <locus>16p13.11</locus>
    <gene_sequence>&gt;1761 bp
ATGCTAGCTCGTGTCACCAGGAAGATGCTACGTCATGCCAAGTGTTTTCAGCGCCTAGCA
ATTTTTGGTTCTGTGAGGGCACTGCATAAAGATAATAGAACAGCAACCCCTCAGAATTTC
TCCAACTATGAATCCATGAAACAGGACTTCAAACTGGGGATTCCAGAGTATTTCAACTTT
GCTAAAGATGTCCTGGACCAATGGACTGATAAGGAAAAGGCTGGAAAGAAACCTTCAAAT
CCAGCCTTCTGGTGGATCAACAGAAATGGAGAAGAGATGCGATGGAGTTTTGAGGAACTG
GGATCTCTGTCCAGAAAATTTGCCAATATACTTTCAGAAGCCTGTTCCCTACAAAGAGGA
GATCGGGTAATTCTGATTCTGCCCAGGGTCCCAGAGTGGTGGCTTGCAAATGTGGCCTGT
CTGCGAACAGGGACAGTTTTAATTCCAGGAACCACTCAGCTGACCCAGAAAGACATTCTC
TACAGACTACAATCTTCAAAAGCAAACTGCATTATCACCAATGATGTTTTAGCCCCAGCA
GTAGACGCTGTTGCATCCAAATGTGAAAATCTGCACTCCAAGCTGATTGTATCAGAGAAC
TCCAGAGAGGGGTGGGGGAACCTCAAGGAGTTGATGAAACATGCCAGTGACAGCCACACC
TGTGTGAAGACAAAACACAATGAGATCATGGCCATATTCTTTACCAGTGGAACAAGTGGA
TATCCGAAAATGACTGCACACACCCACAGCAGTTTTGGTTTAGGATTATCTGTAAATGGA
AGGTTCTGGCTAGATTTGACACCCTCAGATGTGATGTGGAATACCTCAGATACGGGCTGG
GCAAAGTCTGCATGGAGTAGTGTTTTTTCTCCGTGGATCCAGGGAGCATGTGTATTCACA
CACCATTTACCCCGTTTTGAGCCGACTTCTATCTTGCAAACACTCTCCAAGTACCCCATC
ACAGTCTTCTGTTCAGCACCAACTGTATACCGAATGCTTGTACAGAATGATATAACCAGC
TATAAGTTTAAAAGCTTAAAGCACTGTGTGAGTGCTGGGGAACCAATTACCCCTGACGTG
ACTGAAAAATGGAGAAACAAGACGGGCCTGGATATCTACGAAGGATATGGACAGACTGAA
ACGGTGCTAATCTGTGGAAATTTTAAGGGAATGAAAATTAAACCTGGCTCAATGGGAAAA
CCTTCTCCTGCTTTCGATGTTAAGATTGTAGATGTAAATGGCAATGTTCTACCTCCTGGA
CAAGAAGGAGATATTGGCATTCAAGTTCTACCCAACCGACCATTTGGCCTTTTTACTCAT
TACGTAGATAATCCTTCAAAAACAGCTTCAACTCTACGAGGCAATTTCTATATCACTGGG
GACAGAGGATATATGGATAAAGATGGGTATTTCTGGTTTGTTGCAAGAGCAGATGATGTC
ATATTATCCTCTGGCTATCGAATTGGACCATTTGAGGTAGAAAATGCCCTGAATGAACAC
CCTTCAGTTGCAGAGTCAGCTGTTGTCAGCAGCCCAGACCCCATCAGAGGAGAGGTAGTA
AAGGCTTTTGTCGTTCTAAATCCTGATTACAAGTCACATGATCAAGAACAACTAATAAAG
GAGATTCAGGAGCATGTTAAAAAAACTACAGCACCTTACAAATATCCCAGAAAGGTAGAA
TTTATTCAAGAGCTGCCAAAGACTATCAGTGGGAAGACAAAAAGAAATGAACTGAGGAAG
AAAGAATGGAAGACAATTTAA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>586</residue_number>
    <molecular_weight>66152.235</molecular_weight>
    <theoretical_pi>9.041</theoretical_pi>
    <pfams>
      <pfam>
        <name>AMP-binding</name>
        <pfam_id>PF00501</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Acyl-coenzyme A synthetase ACSM3, mitochondrial
MLARVTRKMLRHAKCFQRLAIFGSVRALHKDNRTATPQNFSNYESMKQDFKLGIPEYFNF
AKDVLDQWTDKEKAGKKPSNPAFWWINRNGEEMRWSFEELGSLSRKFANILSEACSLQRG
DRVILILPRVPEWWLANVACLRTGTVLIPGTTQLTQKDILYRLQSSKANCIITNDVLAPA
VDAVASKCENLHSKLIVSENSREGWGNLKELMKHASDSHTCVKTKHNEIMAIFFTSGTSG
YPKMTAHTHSSFGLGLSVNGRFWLDLTPSDVMWNTSDTGWAKSAWSSVFSPWIQGACVFT
HHLPRFEPTSILQTLSKYPITVFCSAPTVYRMLVQNDITSYKFKSLKHCVSAGEPITPDV
TEKWRNKTGLDIYEGYGQTETVLICGNFKGMKIKPGSMGKPSPAFDVKIVDVNGNVLPPG
QEGDIGIQVLPNRPFGLFTHYVDNPSKTASTLRGNFYITGDRGYMDKDGYFWFVARADDV
ILSSGYRIGPFEVENALNEHPSVAESAVVSSPDPIRGEVVKAFVVLNPDYKSHDQEQLIK
EIQEHVKKTTAPYKYPRKVEFIQELPKTISGKTKRNELRKKEWKTI</protein_sequence>
  </protein_properties>
  <genbank_protein_id>42544132</genbank_protein_id>
  <uniprot_id>Q53FZ2</uniprot_id>
  <uniprot_name>ACSM3_HUMAN</uniprot_name>
  <pdb_ids>
  </pdb_ids>
  <genbank_gene_id>NM_005622.3</genbank_gene_id>
  <genecard_id>ACSM3</genecard_id>
  <geneatlas_id>ACSM3</geneatlas_id>
  <hgnc_id>HGNC:10522</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Iwai N, Ohmichi N, Hanai K, Nakamura Y, Kinoshita M: Human SA gene locus as a candidate locus for essential hypertension.  Hypertension. 1994 Mar;23(3):375-80.</reference_text>
      <pubmed_id>7907320</pubmed_id>
    </reference>
    <reference>
      <reference_text>Nabika T, Bonnardeaux A, James M, Julier C, Jeunemaitre X, Corvol P, Lathrop M, Soubrier F: Evaluation of the SA locus in human hypertension.  Hypertension. 1995 Jan;25(1):6-13.</reference_text>
      <pubmed_id>7843754</pubmed_id>
    </reference>
    <reference>
      <reference_text>Loftus BJ, Kim UJ, Sneddon VP, Kalush F, Brandon R, Fuhrmann J, Mason T, Crosby ML, Barnstead M, Cronin L, Deslattes Mays A, Cao Y, Xu RX, Kang HL, Mitchell S, Eichler EE, Harris PC, Venter JC, Adams MD: Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics. 1999 Sep 15;60(3):295-308.</reference_text>
      <pubmed_id>10493829</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Tang LY, Deng N, Wang LS, Dai J, Wang ZL, Jiang XS, Li SJ, Li L, Sheng QH, Wu DQ, Li L, Zeng R: Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction. Mol Cell Proteomics. 2007 Nov;6(11):1952-67. Epub 2007 Aug 12.</reference_text>
      <pubmed_id>17693683</pubmed_id>
    </reference>
    <reference>
      <reference_text>Telgmann R, Brand E, Nicaud V, Hagedorn C, Beining K, Schonfelder J, Brink-Spalink V, Schmidt-Petersen K, Matanis T, Vischer P, Nofer JR, Hasenkamp S, Plouin PF, Drouet L, Cambien F, Paul M, Tiret L, Brand-Herrmann SM: SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study. J Hypertens. 2007 Mar;25(3):557-64.</reference_text>
      <pubmed_id>17278971</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
  </metabolite_references>
</protein>
